N-Con Tonic
- Product NDC
- 68703-338
- 11-digit product format
- 687030338
- Labeler code
- 68703
- Product ID
- 68703-338_8b9a997d-56f3-90a8-e053-2995a90af7bc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Calc fluor, Equisetum arv, Nat phos, Nat sulphuricum, Pulsatilla
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Silver Star Brands
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2019-09-09
- Marketing end
- 0000-00-00
- Substance
- EQUISETUM ARVENSE BRANCH; CALCIUM FLUORIDE; SODIUM SULFATE; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; PULSATILLA VULGARIS
- Active strength
- 6 [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68703-338 | D | Discontinued by firm | 2026-10-12 | ||
| excluded package | package | 68703-338 | 68703-338-30 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 68703-338-30 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 68703-338-30 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 68703-338-30 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 68703-338-30 | 8dfbde2a14a4… | c9ff85d89658… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68703-338-30 | 2023-03-06 | C162847 | 48780-1 | ba0f9c33-3c06-a910-e053-dadaa90a0b85 | NativeRemedies® N-Con Tonic™ |
| 68703-338-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3c06-a910-e053-dadaa90a0b85 | NativeRemedies® N-Con Tonic™ |